- Home
- MASS vs OABI Comparison
MASS vs OABI Comparison
Compare MASS & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASS
- OABI
- Stock Information
- Founded
- MASS 2012
- OABI 2012
- Country
- MASS United States
- OABI United States
- Employees
- MASS N/A
- OABI N/A
- Industry
- MASS Medical/Dental Instruments
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- MASS Health Care
- OABI Health Care
- Exchange
- MASS Nasdaq
- OABI Nasdaq
- Market Cap
- MASS 235.8M
- OABI 228.9M
- IPO Year
- MASS 2020
- OABI N/A
- Fundamental
- Price
- MASS $6.82
- OABI $1.66
- Analyst Decision
- MASS Strong Buy
- OABI Strong Buy
- Analyst Count
- MASS 3
- OABI 3
- Target Price
- MASS $8.00
- OABI $6.67
- AVG Volume (30 Days)
- MASS 294.7K
- OABI 437.1K
- Earning Date
- MASS 11-11-2025
- OABI 11-11-2025
- Dividend Yield
- MASS N/A
- OABI N/A
- EPS Growth
- MASS N/A
- OABI N/A
- EPS
- MASS N/A
- OABI N/A
- Revenue
- MASS $65,560,000.00
- OABI $23,027,000.00
- Revenue This Year
- MASS N/A
- OABI N/A
- Revenue Next Year
- MASS $22.29
- OABI $44.99
- P/E Ratio
- MASS N/A
- OABI N/A
- Revenue Growth
- MASS 37.93
- OABI 6.05
- 52 Week Low
- MASS $1.81
- OABI $1.22
- 52 Week High
- MASS $8.06
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- MASS 63.93
- OABI 46.73
- Support Level
- MASS $5.52
- OABI $1.54
- Resistance Level
- MASS $5.83
- OABI $1.71
- Average True Range (ATR)
- MASS 0.34
- OABI 0.09
- MACD
- MASS 0.13
- OABI 0.01
- Stochastic Oscillator
- MASS 89.82
- OABI 69.77
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.